Related Experiment Video
Updated: May 21, 2026

09:16
Air-sampled Filter Analysis for Endotoxins and DNA Content
Published on: March 7, 2016
Methods for chromatographic removal of endotoxin
Adam J Lowe1, Cameron L Bardliving, Carl A Batt
1Graduate Field of Microbiology, Cornell University, Ithaca, NY, USA. alowe@srcinc.com
Methods in Molecular Biology (Clifton, N.J.)
|June 28, 2012
Summary
Removing endotoxins from therapeutic proteins is crucial. This study introduces a robust method using fast protein liquid chromatography (FPLC) and specialized buffers for effective endotoxin removal at pilot scale.
Area of Science:
- Biotechnology
- Protein Purification
- Process Development
Background:
- Endotoxins, hydrophobic compounds from bacterial outer membranes, contaminate therapeutic proteins produced in bacterial systems.
- Effective endotoxin removal is essential for the safety and efficacy of biopharmaceuticals.
- Current methods like chromatography and filtration face challenges related to protein composition and production scale.
Purpose of the Study:
- To develop and present a robust endotoxin removal method suitable for pilot-scale production.
- To optimize endotoxin clearance using specific chromatography techniques and buffer formulations.
- To address the challenges associated with endotoxin removal in large-scale biomanufacturing.
Main Methods:
- Utilized fast protein liquid chromatography (FPLC) for endotoxin separation.
- Engineered and employed specialized buffer systems designed for enhanced endotoxin binding and removal.
- Validated the method at a pilot production scale.
Main Results:
- Demonstrated a robust and scalable method for significant endotoxin reduction.
- Achieved high-purity therapeutic proteins with minimal endotoxin contamination.
- The developed buffer system proved effective in conjunction with FPLC for endotoxin clearance.
Conclusions:
- The presented FPLC-based method with engineered buffers offers a reliable solution for pilot-scale endotoxin removal.
- This approach facilitates the production of safer therapeutic proteins by effectively addressing endotoxin contamination.
- The method is adaptable and addresses key challenges in large-scale biopharmaceutical manufacturing.

